Patents by Inventor Anthony M. Jevnikar

Anthony M. Jevnikar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PREVENTING IL-2 MEDIATED INFLAMMATION IN EPITHELIAL CELLS
    Publication number: 20100028350
    Abstract: The present invention provides new methods for treating, minimizing and/or preventing inflammatory injury involving IL-2 activity on epithelial cells expressing IL-2 receptors. Methods for reducing or preventing inflammatory injury in a tissue/organ comprise inhibiting IL-2 receptor activity in cells of the tissue/organ.
    Type: Application
    Filed: March 5, 2007
    Publication date: February 4, 2010
    Applicant: London Health Sciences Centre Research Inc.
    Inventors: Anthony M. Jevnikar, Caigan Du
  • Methods and products for controlling the immune responses in mammals
    Publication number: 20020090371
    Abstract: A method is provided for expressing a mammalian antigen in transformed plants to provide a source of plant material for oral or enteral administration to a mammal to produce tolerance to the antigen.
    Type: Application
    Filed: December 7, 2001
    Publication date: July 11, 2002
    Inventors: Anthony M. Jevnikar, Shengwu Ma, Calvin R. Stiller
  • Non-food crop plant bioreactor
    Publication number: 20020038470
    Abstract: A novel method for the production of transgenic proteins of interest suitable for oral administration is disclosed. The method involves the preparation of a protein of interest suitable for oral administration within a non-food crop plant comprising, transforming the non-food crop plant with a suitable vector containing a gene of interest and appropriate regulatory regions to ensure expression of the gene of interest within the non-food crop plant, such that the non-food crop plant is characterized as being non-toxic, non-addictive, palatable, ad requiring minimal or no processing prior to oral administration. An example of a non-food crop plant is low lakaloid tobacco. Proteins of interest may include pharmaceutically active proteins such as growth regulators, insulin, interferons, interleukins, growth hormone, erythropoietin, G-CSF, GM-CSF, hPG-CSF, M-CSF, Factor VIII, Factor IX. tPA, antibodies, antigens and combinations and/or derivatives thereof.
    Type: Application
    Filed: February 1, 2001
    Publication date: March 28, 2002
    Inventors: Jim Brandle, Peter L. Davies, Kimberley D. Kenward, Rima Menassa, Anthony M. Jevnikar, Terry Delovitch
  • Methods and products for controlling the immune response of a mammal to glutamic acid decarboxylase
    Patent number: 6338850
    Abstract: A method is provided for expressing a mammalian antigen in transformed plants to provide a source of plant material for oral or enteral administration to a mammal to produce tolerance to the antigen.
    Type: Grant
    Filed: May 21, 1996
    Date of Patent: January 15, 2002
    Assignee: London Health Sciences Centre
    Inventors: Anthony M. Jevnikar, Shengwu Ma, Calvin R. Stiller